Premium
Circulating and tumor‐infiltrating myeloid cells predict survival in human pleural mesothelioma
Author(s) -
Burt Bryan M.,
Rodig Scott J.,
Tilleman Tamara R.,
Elbardissi Andrew W.,
Bueno Raphael,
Sugarbaker David J.
Publication year - 2011
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.26143
Subject(s) - medicine , cd163 , monocyte , cd68 , cd15 , myeloid , immunohistochemistry , pathology , survival analysis , oncology , tissue microarray , flow cytometry , macrophage , immunology , cd34 , stem cell , biochemistry , chemistry , biology , in vitro , genetics
BACKGROUND: Malignant pleural mesothelioma (MPM) tumor cells produce copious amounts of myeloid cell‐stimulating factors. The current study examined the prognostic significance of circulating monocytes and tumor‐infiltrating macrophages on overall survival in patients with MPM. METHODS: The authors retrospectively reviewed 667 patients with MPM who underwent cytoreductive surgery at the Brigham and Women's Hospital in Boston, Massachusetts between 1989 and 2009. Kaplan‐Meier and Cox proportional hazards models were used to determine the impact of preoperative circulating monocytes on overall survival. Immunohistochemical staining for CD68 was performed on a tissue microarray of MPM tumors from 52 patients undergoing cytoreductive surgery. The phenotype of circulating monocytes and tumor‐infiltrating macrophages in 7 additional patients was determined by flow cytometry. RESULTS: The median survival for all patients was 13.4 months, and 35% of patients had tumors of nonepithelial histology. For patients with nonepithelial compared with epithelial tumors, survival was significantly worse (9.3 months vs 16.6 months; P < .0001), the number of monocytes was significantly higher (580 ± 20 cells/μL vs 520 ± 10 cells/μL; P = .002), and higher monocyte counts were associated with higher tumor stage. Increasing monocyte counts were correlated with poor survival for all patients with MPM. Within MPM tumors, macrophages comprised 27% ± 9% of the tumor area and demonstrated an immunosuppressive phenotype with high expression of CD163, CD206, and interleukin‐4 receptor α. The degree of macrophage infiltration was found to be negatively correlated with survival in patients with nonepithelial ( P = .008) but not those with epithelial ( P = .7) MPM, independent of disease stage. CONCLUSIONS: Higher numbers of circulating monocytes are associated with poor survival in all patients with MPM and higher densities of tumor‐infiltrating macrophages are associated with poor survival in patients with nonepithelial MPM. Both may enable a novel target for immunotherapy. Cancer 2011;. © 2011 American Cancer Society.